UBS Group’s Strata Critical Medical, Inc. Class A Common Stock SRTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.17M | Buy |
289,413
+90,098
| +45% | +$363K | ﹤0.01% | 4230 |
|
|
2025
Q1 | $544K | Sell |
199,315
-22,779
| -10% | -$62.2K | ﹤0.01% | 4622 |
|
|
2024
Q4 | $944K | Buy |
222,094
+67,865
| +44% | +$288K | ﹤0.01% | 4250 |
|
|
2024
Q3 | $453K | Buy |
154,229
+54,758
| +55% | +$161K | ﹤0.01% | 4161 |
|
|
2024
Q2 | $346K | Sell |
99,471
-2,402
| -2% | -$8.36K | ﹤0.01% | 4187 |
|
|
2024
Q1 | $290K | Sell |
101,873
-7,059
| -6% | -$20.1K | ﹤0.01% | 4464 |
|
|
2023
Q4 | $385K | Buy |
108,932
+28,566
| +36% | +$101K | ﹤0.01% | 4163 |
|
|
2023
Q3 | $208K | Sell |
80,366
-10,744
| -12% | -$27.8K | ﹤0.01% | 4244 |
|
|
2023
Q2 | $359K | Sell |
91,110
-587
| -0.6% | -$2.31K | ﹤0.01% | 4073 |
|
|
2023
Q1 | $310K | Buy |
91,697
+2,030
| +2% | +$6.86K | ﹤0.01% | 4038 |
|
|
2022
Q4 | $321K | Sell |
89,667
-9,238
| -9% | -$33.1K | ﹤0.01% | 4018 |
|
|
2022
Q3 | $399K | Buy |
98,905
+18,870
| +24% | +$76.1K | ﹤0.01% | 3554 |
|
|
2022
Q2 | $357K | Buy |
80,035
+7,336
| +10% | +$32.7K | ﹤0.01% | 3577 |
|
|
2022
Q1 | $618K | Sell |
72,699
-13,262
| -15% | -$113K | ﹤0.01% | 3621 |
|
|
2021
Q4 | $759K | Sell |
85,961
-9,247
| -10% | -$81.6K | ﹤0.01% | 3654 |
|
|
2021
Q3 | $990K | Buy |
95,208
+43,765
| +85% | +$455K | ﹤0.01% | 3266 |
|
|
2021
Q2 | $540K | Sell |
51,443
-18,259
| -26% | -$192K | ﹤0.01% | 3691 |
|
|
2021
Q1 | $717K | Buy |
69,702
+68,443
| +5,436% | +$704K | ﹤0.01% | 3650 |
|
|
2020
Q4 | $14K | Buy |
1,259
+689
| +121% | +$7.66K | ﹤0.01% | 6188 |
|
|
2020
Q3 | $6K | Buy |
+570
| New | +$6K | ﹤0.01% | 6323 |
|